Literature DB >> 28011391

Pathophysiology of status epilepticus.

Matthew C Walker1.   

Abstract

Status epilepticus (SE) is the maximal expression of epilepsy with a high morbidity and mortality. It occurs due to the failure of mechanisms that terminate seizures. Both human and animal data indicate that the longer a seizure lasts, the less likely it is to stop. Recent evidence suggests that there is a critical transition from an ictal to a post-ictal state, associated with a transition from a spatio-temporally desynchronized state to a highly synchronized state, respectively. As SE continues, it becomes progressively resistant to drugs, in particular benzodiazepines due partly to NMDA receptor-dependent internalization of GABA(A) receptors. Moreover, excessive calcium entry into neurons through excessive NMDA receptor activation results in activation of nitric oxide synthase, calpains, and NADPH oxidase. The latter enzyme plays a critical part in the generation of seizure-dependent reactive oxygen species. Calcium also accumulates in mitochondria resulting in mitochondrial failure (decreased ATP production), and opening of the mitochondrial permeability transition pore. Together these changes result in status epilepticus-dependent neuronal death via several pathways. Multiple downstream mechanisms including inflammation, break down of the blood-brain barrier, and changes in gene expression can contribute to later pathological processes including chronic epilepsy and cognitive decline.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Drug resistance; Excitotoxicity; Mitochondria; Reactive oxygen species; Status epilepticus

Mesh:

Substances:

Year:  2016        PMID: 28011391     DOI: 10.1016/j.neulet.2016.12.044

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

1.  Calpain activation and neuronal death during early epileptogenesis.

Authors:  Philip M Lam; Marco I González
Journal:  Neurobiol Dis       Date:  2018-11-10       Impact factor: 5.996

2.  Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.

Authors:  Siew-Na Lim; Tony Wu; Wei-En Johnny Tseng; Hsing-I Chiang; Mei-Yun Cheng; Wey-Ran Lin; Chia-Ni Lin
Journal:  J Neurol       Date:  2021-03-22       Impact factor: 4.849

3.  The study of microtubule dynamics and stability at the postsynaptic density in a rat pilocarpine model of temporal lobe epilepsy.

Authors:  Xiaomei Wu; Ying Zhou; Zhiling Huang; Mingfei Cai; Yi Shu; Chang Zeng; Li Feng; Bo Xiao; Qiong Zhan
Journal:  Ann Transl Med       Date:  2020-07

4.  Utility of the END-IT Score to Predict the outcome of Childhood Status Epilepticus: A Retrospective Cohort Study.

Authors:  Dipti Kapoor; Divyani Garg; Rajiv K Malhotra; Virendra Kumar; Suvasini Sharma
Journal:  Ann Indian Acad Neurol       Date:  2021-06-29       Impact factor: 1.383

Review 5.  Laminin as a Biomarker of Blood-Brain Barrier Disruption under Neuroinflammation: A Systematic Review.

Authors:  Juan F Zapata-Acevedo; Valentina García-Pérez; Ricardo Cabezas-Pérez; Monica Losada-Barragán; Karina Vargas-Sánchez; Rodrigo E González-Reyes
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

6.  Systemic thrombin inhibition ameliorates seizures in a mouse model of pilocarpine-induced status epilepticus.

Authors:  Maximilian Lenz; Marina Ben Shimon; Felix Benninger; Miri Y Neufeld; Efrat Shavit-Stein; Andreas Vlachos; Nicola Maggio
Journal:  J Mol Med (Berl)       Date:  2019-10-31       Impact factor: 4.599

7.  Brivaracetam Modulates Short-Term Synaptic Activity and Low-Frequency Spontaneous Brain Activity by Delaying Synaptic Vesicle Recycling in Two Distinct Rodent Models of Epileptic Seizures.

Authors:  Hang Xing; Xiong Han; Sihan Xu; Zhongyu Sun; Shijun Yang
Journal:  J Mol Neurosci       Date:  2022-03-12       Impact factor: 3.444

Review 8.  Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.

Authors:  Jennifer Leigh Green; Wagner Ferreira Dos Santos; Andréia Cristina Karklin Fontana
Journal:  Biochem Pharmacol       Date:  2021-09-24       Impact factor: 5.858

Review 9.  miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases.

Authors:  Jinying Xu; Yangyang Zheng; Yulin Li; Guangfan Chi; Liangjia Wang; Yining Liu; Xishu Wang
Journal:  Cell Mol Neurobiol       Date:  2021-04-22       Impact factor: 4.231

Review 10.  The role of substance P in epilepsy and seizure disorders.

Authors:  Xue Feng Wang; Tong Tong Ge; Jie Fan; Wei Yang; Ran Ji Cui
Journal:  Oncotarget       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.